HOME   Quotation   Tax   Examples Standard-List   Contact-Us   Cart Powered by Google-Search & Google-Books www.ChineseStandard.net Database: 189759 (16 Jan 2022)
  

GB/T 14233.2-2005 (GBT 14233.2-2005)

GB/T 14233.2-2005_English: PDF (GBT14233.2-2005)
Standard IDContents [version]USDSTEP2[PDF] delivered inStandard Title (Description)Related StandardStatusGoogle Book
GB/T 14233.2-2005English155 Add to Cart 0--3 minutes. Auto-delivered. Test methods for infusion, transfusion, injection equipment for medical use -- Part 2: Biological test methods GB/T 14233.2-2005 Valid GB/T 14233.2-2005

BASIC DATA
Standard ID GB/T 14233.2-2005 (GB/T14233.2-2005)
Description (Translated English) Test methods for infusion, transfusion, injection equipment for medical use - Part 2: Biological test methods
Sector / Industry National Standard (Recommended)
Classification of Chinese Standard C31
Classification of International Standard 11.040.20
Word Count Estimation 31,353
Date of Issue 2005-11-17
Date of Implementation 2006-05-01
Older Standard (superseded by this standard) GB/T 14233.2-1993
Quoted Standard GB/T 16886.1; GB/T 16886.4; GB/T 16886.5; GB/T 16886.6; GB/T 16886.10; GB/T 16886.11; GB/T 16886.12
Drafting Organization Jinan, the State Food and Drug Administration Medical Device Quality Supervision and Inspection Center
Administrative Organization State Food and Drug Administration
Regulation (derived from) Announcement of Newly Approved National Standards No. 1, 2006 (No. 88 overall)
Proposing organization State Food and Drug Administration
Issuing agency(ies) General Administration of Quality Supervision, Inspection and Quarantine of the People Republic of China, China National Standardization Administration Committee
Summary This standard specifies: Infusion, transfusion, injection equipment biological test methods. This standard applies to: medical infusion, transfusion, injection equipment.

GB/T 14233.2-2005
GB
NATIONAL STANDARD OF THE
PEOPLE’S REPUBLIC OF CHINA
ICS 11.040.20
C 31
Replacing GB/T 14233.2-1993
Test Methods for Infusion, Transfusion, Injection
Equipment for Medical Use –
Part 2. Biological Test Methods
ISSUED ON. NOVEMBER 17, 2005
IMPLEMENTED ON. MAY 1, 2006
Jointly Issued by. General Administration of Quality Supervision,
Inspection and Quarantine (AQSIQ);
Standardization Administration (SAC) of the People's
Republic of China.
Table of Contents
Foreword ... 3 
Introduction ... 4 
1 Scope ... 5 
2 Normative References ... 5 
3 Sterility Test ... 6 
4 Bacterial Endotoxin Test ... 8 
5 Pyrogen Test ... 11 
6 Acute Systemic Toxicity Test... 13 
7 Hemolytic Test ... 15 
8 Cytotoxicity Test ... 17 
9 Sensitization Test (Maximum Dose Method) ... 21 
10 Intradermal Reaction Test ... 23 
11 Implantation Test ... 24 
Appendix A (Informative) Sub-acute (Sub-chronic) Systemic Toxicity Test
... 29 
Appendix B (Informative) Interaction Test With Blood (Devices) ... 35 
Appendix C (Informative) Preparation of Common Cell Culturing
Solution and Culture Solution ... 48 
Foreword
GB 14233 "Test Methods for Infusion, Transfusion, Injection Equipment for Medical
Use" is divided into two parts.
- Part 1. Chemical Analysis Method;
- Part 2. Biological Test Methods.
This Part is Part 2 of GB/T 14233. This Part replaces GB/T 14233.2-1993 "Test
Methods for Infusion, Transfusion, Injection Equipment for Medical Use - Part 2.
Biological Test Methods". For the 3 tests - sterile, pyrogen and bacterial endotoxin,
this revision directly quotes the applicable chapters and sections of "Chinese
Pharmacopoeia (Part II)", so as to keep in line with the updated and revised edition of
Chinese Pharmacopoeia; cytotoxicity test methods were modified by reference to
GB/T 16886 "Biological Evaluation of Medical Devices"; GB/T 16886 "Biological
Evaluation of Medical Devices" was directly quoted by reference for sensitization,
intradermal reaction and implantation test; test methods for sub-acute (sub-chronic)
systemic toxicity and blood (equipment) interaction were added; product acceptance
judgment indexes were deleted. Appendix A, Appendix B and Appendix C in this Part
are informative.
This Part was proposed by China Food and Drug Administration.
This Part shall be under the jurisdiction of National Technical Committee on Medical
Syringes of Standardization Administration of China.
Drafting organizations of this Part. Jinan Center for Medical Equipment Quality
Supervision and Testing of State Food and Drug Administration, and Tianjin Medical
Biomaterial Monitoring Research Center.
Chief drafting staffs of this Part. You Shaohua, Zhu Xuetao, Liu Xin, Huang Jingchun,
Wang Xin, Zhu Junmei, Wang Kelei, and Hao Shubin.
This Part was first-time issued in March, 1993.
Introduction
The biological test methods provided in this Part are based on the basic principles of
GB/T 16886.1 "Biological Evaluation of Medical Devices. Part 1. Evaluation and
Testing", and are established especially in accordance with the biological evaluation
demand of medical infusion, transfusion and injection equipment. This revision is
made on the basis of the corresponding test methodology principle and test
procedures in GB/T 16886 "Biological Evaluation of Medical Devices" and "Chinese
Pharmacopoeia (Part II)", and according to the characteristics of medical infusion,
transfusion and injection equipment. Therefore, this Part shares methodology identity
property with GB/T 16886 and the methods of "Chinese Pharmacopoeia"; it is
applicable to the method standard of biological performance test of medical infusion,
transfusion and injection equipment.
For the sterile, pyrogen and bacterial endotoxin tests, this revision directly quotes the
applicable chapters and sections of "Chinese Pharmacopoeia", without the year
number of pharmacopoeia noted, so as to be in line with the updated and revised
edition of "Chinese Pharmacopoeia". For the test items without detailed test
procedure given in GB/T 16886, they are refined, e.g. cytotoxicity, acute systemic
toxicity, sub-acute (sub-chronic) systemic toxicity and tests in interaction with blood
(equipment). For the stimulation, sensitization and implantation tests with test
procedures given in detail in GB/T 16886, this revision directly adopts the
corresponding sections of GB/T 16886.
This Part acts as the test method standard; this revision deletes the product
acceptance judgment indexes in the main body, but provides the current general
judgment indexes for reference in article note. The relevant product standards, when
quoting this Part, shall specify the suitable acceptance judgment indexes according to
the product application characteristics.
Test Methods for Infusion, Transfusion, Injection
Equipment for Medical Use –
Part 2. Biological Test Methods
1 Scope
This Part of GB/T 14233 specifies the biological test methods of medical infusion,
transfusion and injection equipment.
This Part is applicable to medical infusion, transfusion and injection equipment.
2 Normative References
The following normative documents contain provisions which, through reference of
this Part of GB/T 14233, constitute provisions of this standard. For dated references,
subsequent amendments (excluding corrigendum) or revisions of these publications
do not apply. However, all parties who enter into an agreement according to this
standard are encouraged to study whether the latest editions of these documents are
applicable. For undated references, the latest edition of the normative documents
referred to applies.
GB/T 16886.1 Biological Evaluation of Medical Devices Part 1. Evaluation and
Testing (GB/T 16886.1-2001, IDT ISO 10993-1.1997)
GB/T 16886.4 Biological Evaluation Of Medical Devices - Part 4. Selection of
Tests for Interactions with Blood (GB/T 16886.4-2003, ISO 10993-4.2000, IDT)
GB/T 16886.5 Biological Evaluation of Medical Devices - Part 5. Test for in Vitro
Cytotoxicity (GB/T 16886.5-2003, ISO10993-5.1999, IDT)
GB/T 16886.6 Biological Evaluation of Medical Devices - Part 6. Tests for Local
Effects after Implantation (GB/T 16886.6-1997, IDT ISO 10993-6.1996)
GB/T 16886.10 Biological Evaluation of Medical Devices - Part 10. Tests for
Irritation and Delayed-type Hypersensitivity (GB/T 16886.10-2005, ISO
10993-10.2002, IDT)
GB/T 16886.11 Biological Evaluation of Medical Devices - Part 11. Tests for
Systemic Toxicity (GB/T 16886.11-1997, IDT ISO 10993-11.1993)
GB/T 16886.12 Biological Evaluation of Medical Devices - Part 12. Sample
Preparation and Reference Materials (GB/T 16886.12-2005, ISO 10993-12.2002,
IDT)
Pharmacopoeia of People's Republic of China Part II
3 Sterility Test
3.1 Purpose
This test inoculates the medical equipment or its vat liquor into culture medium, so as
to test if the test substance is subject to bacteria and fungus contamination.
3.2 Reagent
Sodium chloride solution of which the mass concentration is 9 g/L, and other diluent
and flushing fluid that meet the requirements of Chinese Pharmacopoeia.
3.3 Main Equipment
Super-clean bench, optical microscope, constant temperature incubator, thermostatic
water bath, pressure steam sterilizer, and electric drying oven
3.4 Preparation Before the Test
3.4.1 Instrument sterilization
All the equipment that contact with the test solution shall be sterilized by reliable
method - Put in pressure steam sterilizer at 121°C for 30min or in electric drying oven
at 160°C for 2h.
3.4.2 Disinfection chamber requirements
3.4.2.1 Partial disinfection chamber operating table or super-clean bench shall meet
the requirements of unidirectional airflow area at cleanliness class 100. After
completion of disinfection treatment on the disinfection chamber, the colony number in
the air shall be inspected, with the following methods. Take a petri dish with the
diameter of about 90 mm; for the aseptic operation, inject about 20mL of melted
nutrient agar medium; cultivate at 30°C~35°C for 48h. After it is confirmed as sterile,
take 3 petri dishes; open the upper cover at the mean position of disinfection chamber
operating table or super-clean bench; after exposing for 30min, cover it and place at
30°C~35°C to cultivate for 48h; take out for inspection. The colony number growing on
the 3 petri dishes shall not exceed 1.
3.4.2.2...